QCG
LUNG icon

Quadrant Capital Group’s Pulmonx LUNG Stock Holding History

Quadrant Capital Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11
Closed -$75 – 2056
2025
Q1 		$75 Hold
11
– – ﹤0.01% 2732
2024
Q4 		$75 Hold
11
– – ﹤0.01% 2725
2024
Q3 		$92 Hold
11
– – ﹤0.01% 2724
2024
Q2 		$70 Sell
11
-300
-96% -$2.31K ﹤0.01% 2690
2024
Q1 		$2.88K Buy
311
+69
+29% +$809 ﹤0.01% 2435
2023
Q4 		$3.09K Buy
242
+231
+2,100% +$2.41K ﹤0.01% 2391
2023
Q3 		$114 Sell
11
-266
-96% -$3.08K ﹤0.01% 2671
2023
Q2 		$3.63K Hold
277
– – ﹤0.01% 2280
2023
Q1 		$3.1K Buy
277
+266
+2,418% +$2.63K ﹤0.01% 2338
2022
Q4 		$93 Buy
+11
New +$105 ﹤0.01% 2720
2022
Q2 		– Sell
-21
Closed -$1K – 2647
2022
Q1 		$1K Sell
21
-285
-93% -$7.36K ﹤0.01% 2337
2021
Q4 		$10K Buy
306
+294
+2,450% +$10.7K ﹤0.01% 1630
2021
Q3 		$0 Buy
+12
New +$472 ﹤0.01% 2584

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Quadrant Capital Group's LUNG Position: Q2 2025 in Review

Quadrant Capital Group sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 11 shares — an estimated $75 sold.

Quadrant Capital Group first reported a position in LUNG in Q3 2021 and held it in 13 quarters. The position peaked at $10K in Q4 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

  • Quadrant Capital Group reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 11 Pulmonx shares in Q2 2025, an estimated $75.
  • Quadrant Capital Group first reported a position in Pulmonx in Q3 2021 and held it in 13 quarters.
  • Quadrant Capital Group's Pulmonx position peaked at $10K in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.